Stay up to date with our latest news and upcoming events.

757 Angels and ivWatch Reach Entrepreneurs at Tom Tom Fest

Local business leaders invited to speak at 7th Annual Tom Tom Founders Festival CHARLOTTESVILLE, Va., April 16, 2018 – 757 Angels and ivWatch recently collaborated during an entrepreneurship session at Tom Tom Founders Festival, a week-long celebration of innovators,...

read more

In the News: I’m an Engineer, But I Can’t Fix Stupid

ivWatch’s Gary Warren Discusses Future of Healthcare and Device Development in MD+DI ivWatch President and CEO, Gary Warren, offers his insights on device development and non-traditional human factors in the Medical Device and Diagnostic Industry (MD+DI) article, “I’m...

read more

ivWatch Announces Relocation Commitment to Accommodate Growth

Tech Center Research Park welcomes medical device company as anchor tenant NEWPORT NEWS, Va., March 6, 2018 – ivWatch, the only provider of medical devices for the early detection of intravenous (IV) infiltrations and extravasations, announced today that it is moving...

read more

In the News: Expected Tech Center Anchor to Add 150 Jobs

New Headquarters and Planned Growth Featured in Daily Press and TidewaterBiz The ivWatch commitment to a new headquarter building at Newport News Tech Center was covered in the Daily Press and TidewaterBiz article, “Expected Tech Center Anchor to Add 150 Jobs.” The...

read more

For media inquiries, please contact:

Amara Betoney
ivWatch Manager, Public Relations
Direct: 757-224-2606
Office: 855-489-2824 ext. 7007

ivWatch Logo White

Download Our Whitepaper

Thank you for requesting more information about the ivWatch Clinical Studies. The ivWatch Model 400 is the only continuous monitoring device for the early detection of IV infiltration and extravasation events.

[fc id='6'][/fc]

You have Successfully Subscribed!

Pin It on Pinterest